First FDA approved SBL-3 ClearView Multifocal Intraocular Lens implanted in U.S.
SBL-3 FDA Approved in the US!
The Lenstec SBL-3 is now FDA approved for sale in the United States! We'll have more information soon along with a specialized product launch site where you can learn more about the lens and patients can locate a SBL-3 implanting physician! Click here to see our press release.
lenstec Supports Cambodian Missions
Lenstec Continues Going Green!
We recently installed solar panels on our manufacturing facility in Barbados. This system enables us to manufacture IOL's using clean solar electricity, helping us to combat greenhouse gas emissions and reduce our collective dependence on fossil fuels.
This is combined with Lenstec UK's move to 100% recyclable packaging materials are just a few of the changes we have made in 2021 for a more sustainable future.
Click image below to be taken to the testimonials page.
Videos of Ophthalmologist's experiences with the Softec Precision Series family of iOLs
Lenstec Softec HDM
Raise the Bar for Standard Cataract Outcomes
the SBL-3 Segmented Bifocal Lens
The Lenstec SBL-3 Segmented Bifocal Lens is an asymmetric MIOL that is intended to provide superior HD vision. It is a symmetric segmented multifocal intraocular lens (MIOL) that is designed to improve contrast sensitivity, minimize halos and glare, and provide superior near, intermediate and far vision compared to other presbyopic IOLs.
Learn more >
New! Loading Demonstration Videos for our Injection System!